Mechanism of the formation of DNA-protein cross-links by antitumor cisplatin.
DNA-protein cross-links are formed by various DNA-damaging agents including antitumor platinum drugs. The natures of these ternary DNA-Pt-protein complexes (DPCLs) can be inferred, yet much remains to be learned about their structures and mechanisms of formation. We investigated the origin of these DPCLs and their cellular processing on molecular level using gel electrophoresis shift assay. We show that in cell-free media cisplatin [cis-diamminedichloridoplatinum(II)] forms DPCLs more effectively than ineffective transplatin [trans-diamminedichloridoplatinum(II)]. Mechanisms of transformation of individual types of plain DNA adducts of the platinum complexes into the DPCLs in the presence of several DNA-binding proteins have been also investigated. The DPCLs are formed by the transformation of DNA monofunctional and intrastrand cross-links of cisplatin. In contrast, interstrand cross-links of cisplatin and monofunctional adducts of transplatin are stable in presence of the proteins. The DPCLs formed by cisplatin inhibit DNA polymerization or removal of these ternary lesions from DNA by nucleotide excision repair system more effectively than plain DNA intrastrand or monofunctional adducts. Thus, the bulky DNA-protein cross-links formed by cisplatin represent a more distinct and persisting structural motif recognized by the components of downstream cellular systems processing DNA damage considerably differently than the plain DNA adducts of this metallodrug.
Chválová
Katerina
K
Institute of Biophysics, Academy of Sciences of the Czech Republic, Brno, Czech Republic.
Brabec
Viktor
V
Kaspárková
Jana
J
D000970:Antineoplastic Agents / Q000737:chemistry / Q000633:toxicity*; D002945:Cisplatin / Q000737:chemistry / Q000633:toxicity*; D003432:Cross-Linking Reagents / Q000737:chemistry / Q000633:toxicity*; D004247:DNA / Q000096:biosynthesis / Q000187:drug effects*; D018736:DNA Adducts / Q000737:chemistry; D004260:DNA Repair; D004268:DNA-Binding Proteins / Q000187:drug effects*; D024202:Electrophoretic Mobility Shift Assay
D000970:Antineoplastic Agents; D003432:Cross-Linking Reagents; D018736:DNA Adducts; D004268:DNA-Binding Proteins; C057270:cisplatin-DNA adduct; C034697:transplatin; D004247:DNA; D002945:Cisplatin